William Blair Downgrades Inhibitex (INHX) to Market Perform
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/15/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts INHX Hot Sheet
Price: $26.00 --0%
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 34
Rating Summary:
5 Buy, 5 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 34
Join SI Premium – FREE
William Blair downgraded Inhibitex (NASDAQ: INHX) from Outperform to Market Perform, new price target of $26.00.
For an analyst ratings summary and ratings history on Inhibitex click here. For more ratings news on Inhibitex click here.
Shares of Inhibitex closed at $25.07 yesterday.
For an analyst ratings summary and ratings history on Inhibitex click here. For more ratings news on Inhibitex click here.
Shares of Inhibitex closed at $25.07 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- William Blair Downgrades Clarivate Analytics (CCC) to Market Perform
- Baird Downgrades Align Technology (ALGN) to Neutral
- William Blair Resumes Jasper Therapeutics (JSPR) at Outperform
Create E-mail Alert Related Categories
DowngradesRelated Entities
William BlairSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
